Heart to Heart Nurses

[CE contact hours--see below.] Improving quality of life for patients with heart failure can include lifestyle modifications and require successful behavior change strategies. Learn best practices to apply into your clinical setting from nurse providers Colleen McIlvennan, PhD, DNP, ANP, FAHA, FHFSA, of the University of Colorado in Denver, and Binu Koirala, PhD, MGS, RN, of the Johns Hopkins University School of Nursing in Baltimore. CE LINK: https://pcna.net/?p=10717&post_type=online-course&preview_id=10717 PCNA Behavior Change mini-certifice (CE course): https://pcna.net/professional-development/online-learning/ "Behavior Change mini-certificate" AHA HF Tools & Resources: heart.org/en/health-topics/heart-failure/heart-failure-tools-resources Adherence to Healthy Sleep Patterns: ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.050792?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed& Addressing Social Determinants of Health in Patients with HF: ahajournals.org/doi/10.1161/CIR.0000000000000767 See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

[CE contact hours--see below.] Health equity issues, including access ot medications, significantly impact patients with heart failure. From pharmacy deserts to non-medical switching and beyond, hear strategies to assist patients in getting the medications they need, from nurses Binu Koirala, PhD, MGS, RN, with the Johns Hopkins University School of Nursing in Baltimore, and Kim Newlin, MSN, ANP, FPCNA, of Sutter Roseville Medical Center in Northern California.  CE LINK: https://pcna.net/?p=10716&post_type=online-course&preview_id=10716  Access to Innovative Medicines Provider Tools: https://pcna.net/clinical-resources/provider-tools/access-for-innovative-medicines-provider-tools/ Medicare State Pharmaceutical Assistance Program: medicare.gov/pharmaceutical-assistance-program/#state-programs Extra Help with Medicare Prescription Drug Care Costss: ssa.gov/benefits/medicare/prescriptionhelp.html CoverMyMeds: covermymeds.com/main/ Solving Medication Access issues: acc.org/latest-in-cardiology/articles/2020/10/01/01/42/feature-advancing-health-equity-for-heart-failure-patients Non-Medical Switching: cga.ct.gov/2017/rpt/2017-R-0008.htm#:~:text=%E2%80%9CNon%2Dmedical%20switching%E2%80%9D%20broadly,expensive%20but%20therapeutically%20equivalent%20drug Health Equity: cdc.gov/chronicdisease/healthequity/index.htm Understanding Copay Accumulators: https://infusioncenter.org/understanding-copay-accumulators-who-really-benefits/ PACH (Partnership to Advance Cardovascular Health): advancecardiohealth.org/ See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

[CE contact hours--see below.] Often prescribed for obesity, SGLT2is and GLP-1 RAs have a role in heart failure management. Learn about their mechanisms of action, and how their use extends beyond weight loss to cardioprotective and renalprotective properties. Guests: Kim Newlin, MSN, ANP, FPCNA, of Sutter Roseville Medical Center in Northern California, and Colleen McIlvennan, PhD, DNP, ANP, FAHA, FHFSA, from the University of Colorado in Denver.   CE Link: https://pcna.net/?p=10718&post_type=online-course&preview_id=10718  2022 AHA/ACC/HFSA 2022 Guideline for the Managment of HF: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063 Pocket Guide: Guidelines for Managing CVD Risk in Patients with Diabetes: https://pcna.net/clinical-resources/provider-tools/diabetes-provider-tools/ HF Pocket Guide: A Guide to Prevention and Management: https://pcna.net/clinical-resources/provider-tools/heart-failure-provider-tools/  New and Emerging Treatments for Heart Failure: HFrEF and HFpEF (CE course): https://pcna.net/online-course/new-and-emerging-treatments-for-heart-failure-hfref-and-hfpef/  SGLT2is in Heart Failure: ncbi.nlm.nih.gov/pmc/articles/PMC8654149/ SGLT2i in HFpEF: multicenter randomized trial: nature.com/articles/s41591-021-01536-x Empagliflozin in HFpEF: https://www.nejm.org/doi/10.1056/NEJMoa2107038#:~:text=Empagliflozin%20in%20HF%20with%20Preserved%20Ejection%20Fraction&text=Sodium%E2%80%93glucose%20cotransporter%202%20(SGLT2,and%20a%20reduced%20ejection%20fraction.  See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Atrial fibrillation (AFib) management includes both pharmacologic and non-pharmacologic therapies.Guest Bill Miles, MD, FACC, of the University of Florida, Gainsville, describes how to effectively treat AFib--from asymptomatic younger patients without left ventricular dysfunction to older patients with significantly reduced ejection fraction. AFib resources for patients AFib resources for healthcare providers See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The interrelationship of sleep apnea and atrial fibrillation (AFib) should be front of mind for clinicians. Learn keys to guideline-directed therapy including diagnosis, risk scores, the importance of anticoagulation, rate- and rhythm-controlling medications, and pacemakers, from guest Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, Unitypoint Health Allen Hospital Cardiovascular Center. AFib resources for patients AFib resources for healthcare providers See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Sexual and gender minorities--those identified as LGBQT+--are at increased risk of cardiovascular disease. Investigate the connections between heart health and minority stressors, poverty, care delays or avoidance, discrimination, and other factors affecting our patients, and how nurses can positively impact care and outcomes. Guest: Billy Cacaeres, PhD, RN, AGPCNC-BC, FAAN, of Columbia University. Gay and Lesbian Medical Association glma.org National LGBTQIA+ Education Center lgbtqiahealtheducation.org See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Cardiovascular disease prevention can--and should--begin before patients develop any risk factors. Learn about strategies for primoridial prevention (including maternal risks of CVD), reducing health disparities, and how they can be applied in clinical practice--no matter where patients are in their lifespan. Guest: Don Lloyd-Jones, President of the American Heart Association, and Chair of the Dept. of Preventive Medicine at Northwestern University. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Familial Hypercholesterol, the genetic condition that causes high LDL cholesterol levels, may lead to early heart attacks or heart disease If undiagnosed or untreated. Guest Susan Halli Demeter, DNP, CNP, NP, of the Mayo Clinic, describes diagnosis, heterozyogus and homozygous versions, treatments, and the importance of genetic screening for family members. CE course The Role of Non-Statin Therapies in Optimal Cholesterol Management Patient education What is Familial Hypercholesterolemia? Patient & professional tools: Access to Innovative Medicines See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Developing and demonstrating leadership--regardless of your job title--helps improve patient outcomes, job satisfaction, and career advancement. Learn about the Future of Nursing repot, and how mentorship, training, and resources can help you in your career journey. Guest: Sandra B. Dunbar, RN, PhD, FAAN, FAHA, FPCNA, of Emory University. Advancing the Cardiovascular Nursing Profession: https://pcna.net/advancing-the-cardiovascular-nursing-profession/  PCNA Leadership Series: https://pcna.net/event/leadership-series-leadership-in-the-workplace/  See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Cardio-oncology requires a team of individuals--primary care, oncology, cardiology, families, and caregivers--supporting the patient and the shared decision-making process. The COVID-19 pandemic effects on cardio-oncology are discussed, along with informational resources. Guests: Janet Celli, BSN, RN, PCCN, and Kerry Skurka, RN, BSN, F-ICOS.  Resources: American College of Cardiology CardioSmart: cardiosmart.org ICOS: ic-os.org Cancer Support Community: cancersupportcommunity.org Association of Community Cancer Centers: accc-cancer.org Little Red Door: littlereddoor.org See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Patients with cancer are at increased risk of cardiovascular disease, months or years following their final cancer treatment--and the comorbidities for cancer and CVD overlap significantly. Guests Janet Celli, BSN, RN, PCCN, and Kerry Skurka, RN, BSN, F-ICOS, discuss risk reduction and the impact of health equity in these patients. Resources: American College of Cardiology CardioSmart: cardiosmart.org ICOS: ic-os.org Cancer Support Community: cancersupportcommunity.org Association of Community Cancer Centers: accc-cancer.org K Red Door: littlereddoor.org See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

A relatively new field, and a fast growing subspecialty, cardio-oncology addresses cardiovascular disease, or side effects, associated with cancer. Guests Janet Celli, BSN, RN, PCCN, and Kerry Skurka, RN, BSN, F-ICOS, discuss the clinical implications for patients who may experience cardiovascular disease during, or following, cancer treatment.  Resources: American College of Cardiology CardioSmart: cardiosmart.org ICOS: ic-os.org Cancer Support Community: cancersupportcommunity.org Association of Community Cancer Centers: accc-cancer.org Little Red Door: littlereddoor.org See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In Hypertrophic Cardiomyopathy (HCM), left ventricle wall thickening reduces the heart's ability to pump blood efficiently. HCM treatment options are limited, and shared decision-making with patients, family members, and healthcare teammates is crucial throughout the disease journey. Guest: Deatrah Dubose, APN, of the Chanin T. Mast Center at Atlantic Health. https://www.medscape.com/viewarticle/975122 See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hypertrophic Cardiomyopathy (HCM) diagnosis and management complicated; symptoms may include shortness of breath, severe arrhythmias, or inability to exercise. Rarely, very vigorous physical activity may trigger dangerous arrhythmias and even sudden cardiac arrest. Centers of Excellence provide best practice approaches to optimize patient outcomes. Guests include Heidi Salisbury, RN, MSN, CNS, from Stanford University, and Carol Patrick, RN, ACNP, from Northwell Health. 2020 AHA/ ACC Guidelines for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy , JACC, 76 (25), 2020.  https://www.jacc.org/doi/10.1016/j.jacc.2020.08.045 AHA Scientific Statement 12-step screening for SCD in High School Athletes 2016 HCM Centers of Excellence https://4hcm.org/center-of-excellence/ See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hypertrophic Cardiomyopathy (HCM) is the most common genetic heart disease in the United States, with 1 in 500 (0.2%) diagnosed with the condition worldwide. Learn about the basics: signs, symptoms and diagnosis of HCM with guest Jane A. Linderbaum MS, ARNP, FACC, Associate Professor of Medicine at the Mayo Clinic.  Patient Education Resource: Hypertrophic Cardiomyopathy: What You Need to Know https://pcna.net/clinical-resources/patient-handouts/hypertrophic-cardiomyopathy-patient-tool/ See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.